Feasibility Study for the Assessment of Sleep Quality in Men With Prostate Cancer Starting ADT
Feasibility of Using the ARESTM Device to Measure Sleep Parameters in Men With Asymptomatic Prostate Cancer Before as Well as at 3 and 6 Months After Starting Androgen Deprivation Therapy
Sponsor: Vancouver Prostate Centre
A observational or N/A phase clinical study on Prostatic Neoplasms and Sleep, this trial is completed. The trial is conducted by Vancouver Prostate Centre and has accumulated 8 data snapshots since 2015. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.
Status Flow
Change History
8 versions recorded-
Sep 2024 — Present [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Jan 2021 — Jul 2024 [monthly]
Completed
-
Nov 2019 — Jan 2021 [monthly]
Completed
Status: Recruiting → Completed
-
Jun 2018 — Nov 2019 [monthly]
Recruiting
▶ Show 3 earlier versions
-
Apr 2018 — Jun 2018 [monthly]
Recruiting
Phase: NA → None
-
Feb 2018 — Apr 2018 [monthly]
Recruiting NA
-
Jan 2017 — Feb 2018 [monthly]
Recruiting NA
First recorded
Jul 2015
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Vancouver Prostate Centre
For direct contact, visit the study record on ClinicalTrials.gov .